Publicacions (355) Publicacions de JOSE VICENTE CASTELL RIPOLL

2024

  1. A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy

    Toxicology, Vol. 509

  2. Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study

    Microchemical Journal, Vol. 198

  3. Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data

    Analytica chimica acta, Vol. 1286, pp. 342052

  4. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

  5. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  6. Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

    Applied Spectroscopy Reviews, Vol. 59, Núm. 4, pp. 578-599

  7. Protectiveness of NAM-based hazard assessment - which testing scope is required?

    ALTEX, Vol. 41, Núm. 2, pp. 302-319

  8. Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders

    Alternatives to Laboratory Animals, Vol. 52, Núm. 2, pp. 117-131

  9. Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches

    Toxicology, Vol. 504

2023

  1. A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

  2. Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds

    Stem cells (Dayton, Ohio), Vol. 41, Núm. 11, pp. 1076-1088

  3. Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation

    The Analyst, Vol. 148, Núm. 17, pp. 3986-3991

  4. Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference

    Analyst, Vol. 148, Núm. 13, pp. 3097-3106

  5. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients

    Nutrients, Vol. 15, Núm. 14

  6. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved

    Archives of Toxicology, Vol. 97, Núm. 6, pp. 1723-1738

  7. The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics

    Frontiers in Pharmacology, Vol. 14

2022

  1. A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes

    Journal of Proteome Research, Vol. 21, Núm. 3, pp. 702-712

  2. Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection

    Scientific Reports, Vol. 12, Núm. 1

  3. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay

    Toxicology Letters, Vol. 368, pp. 33-46

  4. Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen

    Antioxidants, Vol. 11, Núm. 5